Literature DB >> 12061729

Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study.

Takanari Ohno1, Toshihiko Wakabayashi, Atsuhito Takemura, Jun Yoshida, Akira Ito, Masashige Shinkai, Hiroyuki Honda, Takeshi Kobayashi.   

Abstract

Various kinds of hyperthermic treatment for malignant glioma had been inhibited due to both their incomplete feverish action and strict cooling effect of the brain. The author shows an effective results of hyperthermia for the treatment of malignant glioma in an in vivo study using stick type carboxymethylcellulose (CMC)-magnetite, a newly manufactured magnetite-product. A stick type CMC-magnetite, containing magnetite particles, was inserted into the T-9 glioma in the rat brain stereotactically, and the rats were exposed to an alternative magnetic field (AMF). The application time of AMF, which measured 88.9 kHz and 380 Oe, was 30 min a day. The rats were divided into three groups: three AMF applications (group I), one AMF application (group II) and no application but only injection of CMC-magnetite (control). As a result, the mean survival in days of these three groups measured 44.2+/-10.9 (group I), 17.0+/-1.5 (group II) and 14.4+/-1.5 (control). This investigation showed both significant effectiveness in attacking malignant glioma and significant prolonging of the survival time in rats. It is also a characteristic feature of the magnetite particles to spread through the tumor diffusely after three applications of AMF. This feature seemed to be one of the main factors that caused greater hyperthermic effect on glioma in this study. This method of hyperthermic treatment could be a useful strategy in the treatment of malignant glioma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061729     DOI: 10.1023/a:1015080808031

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  Interstitial thermotherapy of central brain tumors with the Nd:YAG laser under real-time monitoring by MRI.

Authors:  P W Ascher; E Justich; O Schröttner
Journal:  J Clin Laser Med Surg       Date:  1991-02

2.  Regional differences in apoptosis in murine gliosarcoma (T9) induced by mild hyperthermia.

Authors:  J Moroi; S Kashiwagi; S Kim; M Urakawa; H Ito; K Yamaguchi
Journal:  Int J Hyperthermia       Date:  1996 May-Jun       Impact factor: 3.914

3.  Heat-induced damage to HeLa-S3 cells: correlation of viability, permeability, osmosensitivity, phase-contrast light-, scanning electron- and transmission electron-microscopical findings.

Authors:  D N Wheatley; C Kerr; D W Gregory
Journal:  Int J Hyperthermia       Date:  1989 Mar-Apr       Impact factor: 3.914

4.  Brachytherapy and hyperthermia for malignant astrocytomas.

Authors:  P K Sneed; D A Larson; P H Gutin
Journal:  Semin Oncol       Date:  1994-04       Impact factor: 4.929

5.  Effect of different whole body hyperthermic sessions on the heat shock response in mice liver and brain.

Authors:  S Leoni; D Brambilla; G Risuleo; G de Feo; G Scarsella
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

6.  Enhancement of ACNU treatment of the BT4An rat glioma by local brain hyperthermia and intra-arterial drug administration.

Authors:  B C Schem; B K Krossnes
Journal:  Eur J Cancer       Date:  1995-10       Impact factor: 9.162

7.  Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia.

Authors:  K Kakinuma; R Tanaka; H Takahashi; M Watanabe; T Nakagawa; M Kuroki
Journal:  J Neurosurg       Date:  1996-02       Impact factor: 5.115

8.  Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats.

Authors:  Y Sakaguchi; L C Stephens; M Makino; T Kaneko; F R Strebel; L L Danhauser; G N Jenkins; J M Bull
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes.

Authors:  M Yanase; M Shinkai; H Honda; T Wakabayashi; J Yoshida; T Kobayashi
Journal:  Jpn J Cancer Res       Date:  1998-07

10.  Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study.

Authors:  M Yanase; M Shinkai; H Honda; T Wakabayashi; J Yoshida; T Kobayashi
Journal:  Jpn J Cancer Res       Date:  1997-07
View more
  8 in total

1.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

2.  Development of a highly efficient implanted thermal ablation device: in vivo experiment in rat liver.

Authors:  H Matsui; M Hamuro; K Nakamura; H Kayahara; K Murano; Y Kotsuka; Y Miki
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

Review 3.  Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.

Authors:  Keon Mahmoudi; Alexandros Bouras; Dominique Bozec; Robert Ivkov; Constantinos Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2018-02-06       Impact factor: 3.914

4.  The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma.

Authors:  Andreas Jordan; Regina Scholz; Klaus Maier-Hauff; Frank K H van Landeghem; Norbert Waldoefner; Ulf Teichgraeber; Jens Pinkernelle; Harald Bruhn; Fabian Neumann; Burghard Thiesen; Andreas von Deimling; Roland Felix
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

5.  The safety and efficacy of magnetic nano-iron hyperthermia therapy on rat brain glioma.

Authors:  Guo-qing Yi; Bin Gu; Lu-kui Chen
Journal:  Tumour Biol       Date:  2013-10-28

Review 6.  Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment.

Authors:  André C Silva; Tiago R Oliveira; Javier B Mamani; Suzana M F Malheiros; Luciana Malavolta; Lorena F Pavon; Tatiana T Sibov; Edson Amaro; Alberto Tannús; Edson L G Vidoto; Mateus J Martins; Ricardo S Santos; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2011-03-25

7.  Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model.

Authors:  Matthew T Basel; Sivasai Balivada; Hongwang Wang; Tej B Shrestha; Gwi Moon Seo; Marla Pyle; Gayani Abayaweera; Raj Dani; Olga B Koper; Masaaki Tamura; Viktor Chikan; Stefan H Bossmann; Deryl L Troyer
Journal:  Int J Nanomedicine       Date:  2012-01-18

8.  Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.

Authors:  Raphaël Le Fèvre; Mickaël Durand-Dubief; Imène Chebbi; Chalani Mandawala; France Lagroix; Jean-Pierre Valet; Ahmed Idbaih; Clovis Adam; Jean-Yves Delattre; Charlotte Schmitt; Caroline Maake; François Guyot; Edouard Alphandéry
Journal:  Theranostics       Date:  2017-10-13       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.